Nulibry 9.5 mg lyophilized powder for injection Images
Generic Name: fosdenopterin
This medication has been identified as Nulibry 9.5 mg lyophilized powder for injection. It is supplied by Sentynl Therapeutics, Inc.
Nulibry is used in the treatment of Molybdenum Cofactor Deficiency Type A and belongs to the drug class miscellaneous metabolic agents. Nulibry 9.5 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Nulibry
- Generic Name
- fosdenopterin
- Strength
- 9.5 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sentynl Therapeutics, Inc.
- Manufacturer
- Alcami Carolinas Corporation
- National Drug Code (NDC)
- 73129-0001 (Discontinued)
See also:
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
More about Nulibry (fosdenopterin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.